can i take glp 1 on an empty stomach Glucagon-Like Peptide-1 Agonists and General Anesthesia: Perioperative Considerations and the Utility of Gastric Ultrasound Semaglutide on Empty Stomach: Timing

Retatrutide, a triple-agonist (GLP-1, GIP and glucagon), is in late-stage trials and has produced even more weight loss in early data up to 24% at 48 weeks in phase 2

Clinician evaluation

It facilitates improving hydration

In an elderly patient, should I prescribe Jardiance (empagliflozin) or a GLP-1 (glucagon-like peptide-1) receptor agonist for glycemic control?

They are generally avoided in individuals with: Personal or family history of Medullary Thyroid Carcinoma (MTC) Multiple Endocrine Neoplasia Syndrome Type 2 (MEN2) Additional caution may be required for individuals with: History of pancreatitis Severe gastrointestinal disorders such as gastroparesis Pregnancy Breastfeeding A thorough medical assessment should always occur before beginning treatment